AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Novanta Inc.
Video analysis: NOVT
All videosNo video analysis for this stock yet. Request one from our team.
News: NOVT
Are Robots the New Normal? Bet on these ETFs to Invest in the Future
Robotics is entering a new era as AI fuels humanoid adoption, with four ETFs offering diversified exposure to the sector's growth.
Connor Clark & Lunn Investment Management Ltd. Makes New Investment in Novanta Inc. $NOVT
Connor Clark and Lunn Investment Management Ltd. acquired a new position in Novanta Inc. (NASDAQ: NOVT) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 4,845 shares of the technology company's stock, valued at approximately $786,000. Several other large investors have
Novanta to Present at Baird Global Healthcare Conference on Tuesday, September 15, 2026
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and John Lesica, Chief Operating Officer of Medical Solutions, are scheduled to present at the Baird Global Healthcare Conference on Tuesday, September 15, 2026, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical a.
Recent Price Trend in Novanta (NOVT) is Your Friend, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Novanta (NOVT) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Are You Looking for a Top Momentum Pick? Why Novanta (NOVT) is a Great Choice
Does Novanta (NOVT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Novanta Inc. $NOVT Shares Bought by Bank of America Corp DE
Bank of America Corp DE increased its stake in Novanta Inc. (NASDAQ: NOVT) by 18.3% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 456,241 shares of the technology company's stock after acquiring an additional 70,728 shares during the
Amundi Purchases 3,516 Shares of Novanta Inc. $NOVT
Amundi increased its position in shares of Novanta Inc. (NASDAQ: NOVT) by 17.9% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 23,187 shares of the technology company's stock after buying an additional 3,516 shares during the quarter. Amundi owned 0.07% of
Novanta Q2 Earnings Call Highlights
Novanta (NASDAQ: NOVT) reported second-quarter results marked by 9% organic sales growth, expanding margins and higher operating cash flow, while raising its full-year outlook following the late-July closing of its Riverpoint Medical acquisition. Chair and Chief Executive Officer Matthijs Glastra said reported revenue grew 10% year over year during the quarter, while adjusted EBITDA increased 16%
Similar companies
-
Itron, Inc.
ITRI
·
NASDAQ
Compare
-
OSI Systems, Inc.
OSIS
·
NASDAQ
Compare
-
Sensata Technologies Holding plc
ST
·
New York Stock Exchange
Compare
-
Vicor Corporation
VICR
·
NASDAQ
Compare
-
Badger Meter, Inc.
BMI
·
New York Stock Exchange
Compare
-
ESCO Technologies Inc.
ESE
·
New York Stock Exchange
Compare